Which of the following tumors would most likely be associated with either hyponatremia or diffuse pigmentation of skin?
Hyponatremia can be caused by the syndrome of inappropriate antidiuretic hormone secretion (SIADH), which is often associated with small cell lung cancer. But there are other tumors too. Skin pigmentation is a sign of ectopic ACTH production leading to Cushing's syndrome, which can be caused by small cell lung cancer as well. Wait, so if a tumor secretes ACTH, it can cause Cushing's, leading to hyperpigmentation because ACTH has melanocyte-stimulating activity.
So the tumor causing both hyponatremia and skin pigmentation might be one that secretes both ADH and ACTH. But small cell lung cancer is known for causing both SIADH and Cushing's. Let me check. Yes, small cell lung cancer (SCLC) can produce both ADH and ACTH. So the answer is SCLC.
Now, let's structure the explanation. The core concept is ectopic hormone production. The correct answer is SCLC. The other options: maybe medullary thyroid carcinoma (MTC) causes C-cell hyperplasia and hypercalcitoninemia, not these symptoms. Pheochromocytoma causes hypertension, not hyponatremia or pigmentation. Carcinoid tumors can cause carcinoid syndrome, which includes flushing but not these.
Clinical pearl: Remember that SCLC is a common cause of paraneoplastic syndromes, including SIADH and Cushing's. So the correct answer is C. Small cell lung cancer. Need to make sure each part of the explanation is accurate and concise.
**Core Concept**
The question tests knowledge of paraneoplastic syndromes caused by tumor-secreted hormones. **Hyponatremia** (SIADH) and **diffuse skin pigmentation** (ectopic ACTH) are classic signs of **ectopic hormone production**, commonly seen in **small cell lung cancer (SCLC)**.
**Why the Correct Answer is Right**
**Small cell lung cancer (SCLC)** frequently secretes **antidiuretic hormone (ADH)** (causing SIADH and hyponatremia) and **adrenocorticotropic hormone (ACTH)** (stimulating melanocytes via melanocyte-stimulating hormone, leading to hyperpigmentation). This dual hormone secretion creates a unique paraneoplastic profile. SCLCβs neuroendocrine origin explains its ability to produce these bioactive peptides.
**Why Each Wrong Option is Incorrect**
**Option A:** *Medullary thyroid carcinoma* causes **hypercalcitoninemia** and C-cell hyperplasia, not hyponatremia or pigmentation.
**Option B:** *Pheochromocytoma* secretes **catecholamines**, causing episodic hypertension, not electrolyte or pigmentation changes.
**Option D:** *Carcinoid tumors* produce **serotonin**, leading to carcinoid syndrome (flushing, diarrhea), not the described symptoms.
**Clinical Pearl / High-Yield